期刊文献+

齐拉西酮联合改良电抽搐治疗对精神分裂症患者认知功能的影响 被引量:4

Effects of ziprasidone combined with MECT on cognitive function of schizophrenia patient
下载PDF
导出
摘要 目的探讨齐拉西酮联合改良电抽搐治疗对精神分裂症患者认知功能的影响。方法将54例精神分裂症患者随机分为研究组和对照组各27例,两组均口服齐拉西酮治疗,研究组在此基础上联合改良电抽搐治疗,观察5周。于治疗前及治疗5周末采用连线测验、数字符号转换测验、言语流畅性测验、数字广度测验评定认知功能,采用阳性与阴性症状量表评定临床疗效。结果治疗5周末两组阳性与阴性症状量表总分及各因子分均较治疗前显著下降(P〈0.01),同期两组间评分比较差异均无显著性(P〉0.05)。治疗5周末两组连线测验A、连线测验B测试所耗时间及研究组数字符号转换测验评分均较治疗前显著下降(P〈0.05或0.01);治疗前两组各项测验结果比较差异无显著性(P〉0.05),治疗后研究组数字符号转换测验评分显著低于对照组(P〈0.01),其他测验结果两组比较差异均无显著性(P〉0.05)。结论齐拉西酮联合改良电抽搐治疗精神分裂症疗效显著,且与单用齐拉西酮相当;对患者的精神运动速度和言语功能无明显影响,对注意力有一定损害,对工作记忆有显著改善作用。 Objective To explore the influences of ziprasidone plus modified electroconvulsive therapy (MECT) on cognitive function of schizophrenia patient. Methods Fifty-four patients with schizophrenia were randomly assigned to two groups of 27 ones each, both groups received ziprasidone treatment, and research group was plus MECT for 5 weeks. Cognitive functions were assessed with the Trail Making Test (TMT), Symbol Digit Modalities Test (SDMT), Verbal Fluency Test (VFT) and Digit Span Test (DST) and efficacies with the Positive and Negative Syndrome Scale (PANSS) at baseline and the end of the 5^th week. Results At the end of the 5^th week, the total and each factor score of the PANSS of both groups lowered more significantly compared with pretreatment (P〈0.01), there were no significant differences in contemporary group comparisons (P〈0.05). At the end of the 5^th week, time consumptions of TMT-A and -B and SDMT score of both groups lowered more significantly compared with pretreatment (P〈0.05 or 0.01) ; there were no significant differences in each test result before treatment (P〈0.05), after treatment SDMT score was significantly lower in research than in control group (P〈0.01) and there were no significant group differences in other tests (P〈0.05). Conclusion Ziprasidone plus MECT has an evident effect equivalent to ziprasidone in the treatment of schizophrenia; that has no notable effects on psychomotor speed and speech function, impairs attention certainly and improves working memory notably.
出处 《临床心身疾病杂志》 CAS 2012年第6期533-536,共4页 Journal of Clinical Psychosomatic Diseases
关键词 精神分裂症 齐拉西酮 改良电抽搐治疗 认知功能 阳性和阴性症状量表 Schizophrenia ziprasidone MECT cognitive function PANSS
  • 相关文献

参考文献10

  • 1Datto CJ, Levy S, Miller DS, et al. Impact of mainte- nance ECT on concentration and memory [J]. J ECT, 2001, 17(3):170.
  • 2Rami I., Bernardo M, Boget T, et al. Cognitive status of psychiatric patients under maintenance electroconvulsive therapy: a one year longitudinal study [J]. J Neuropsychia try Clin Neurosci, 2004, 16(4): 465.
  • 3Porter R, Heenan H, ReevesJ. Early effects of electro convulsive therapy on cognilive function [J]. J ECT, 2008, 24(1):35.
  • 4Keefe RS, Bilder RM, Harvey PD, et al. Baseline new rocognitive deficits in the CATIE schizophrenia trial [J]. Neuropsychopharmacology, 2006, 31(9): 2 033.
  • 5姜玮,路亚洲.不同波宽刺激下无抽搐电痉挛治疗情感障碍患者的疗效及对认知功能的影响[J].中国心理卫生杂志,2010,24(9):669-673. 被引量:9
  • 6Rose BD, Fleischmann P, Wykes T, et al. Patients' perspectives on electroconvulsive therapy: systematic review[J]. BMJ, 2003, 326(7 403): 1 363.
  • 7Rami Conzalez L, Bernardo M, Boget T, et al. Sub types of memory dysfunction associated with ECT= charac teristics and neurobiological bases [J]. J ECT, 2001, 17 (2) :129.
  • 8Rami L, Bernardo M, Valdes M, et al. Absence of ad ditional cognitive impairment in schizophrenia patients during maintenance electroconvulsive therapy [J]. Schizophr Bull, 2004, 30(1): 185.
  • 9Karayal ON, Glue P, t3achinsky M, et, aL Switching ftom quetiapine to ziprasidone: a sixteen-week, open label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects whh schizophrenia or schizoaffective disorder [J]. J Psychiatr Pract, 2011,17(2): 100.
  • 10Meltzer HY, Sumiyoshi T. Does stimulation of 5-HT (1A) receptors improve cognition in schizophren a? [J]. Be hav Brain Res, 2008, 195(1): 98.

二级参考文献17

  • 1潘能荣,杨小男,张承安,梅其一.电休克治疗对抑郁症的疗效研究[J].临床精神医学杂志,2005,15(2):75-77. 被引量:76
  • 2吴强,李艳红.无抽搐电休克治疗精神障碍疗效分析[J].临床精神医学杂志,2006,16(2):105-105. 被引量:80
  • 3龚耀先,江达威,邓君林,等.修订韦氏记忆量表手册[M].长沙:湖南医科大学,1989:2-10.
  • 4汤毓华.汉密顿抑郁量表.中国心理卫生杂志,1999,12.
  • 5Persad E.Electroconvulsive therapy in depression[J].Can J psychiatry,1990,35(2):175-182.
  • 6Berman RM,Prudic J,Brakemeier EL,et al.Subjective evaluation of the therapeutic and cognitive effects of electroconvulsive therapy[J].Brain Stimulation,2008,1(1):16-26.
  • 7Sackeim HA,Prudic J,Nobler MS,et al.Effects of puluse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy[J].Brain Stimulation,2008,1(2):71-83.
  • 8Prudac J,Pester S,Sackeim HD,et al.Subjective memory complaints:a review of patient self assessment of memory after electroconvulsive therapy[J].J ECT,2000,16(2):121-132.
  • 9Mccall WV,Reboussim DM,Weiner RD,et al.Titrated moderately Suprathreshold vs fixed high dose right unilateral electroconvulsive therapy:a cute untidepressant and cognitive effects[J].Arch Gen Psychiatry,2000,57(5):438-444.
  • 10Young RC,Biggs JT,Ziegier VE,et al.A rating scale for mania:reliability,validity and sensitivity[J].Br J Psychiatry,1978,133(11):429-435.

共引文献8

同被引文献34

  • 1胡峻梅,王洪明,李涛,李奕,刘协和.首发精神分裂症病人的认知功能研究[J].中国行为医学科学,2004,13(4):421-422. 被引量:12
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准[M].第3版.济南:山东科学技术出版社,2001:75-77.
  • 3Blackwood D. P3o0 , a state and a trait marker in schizo- phrenia [J]. lancet, 2000, 355(9206) : 771.
  • 4Wagner P, R6schke J,Gr6zinger M, et al. A replication study on P3oo single trial analysis in schizophrenia :confirma- tion of a reduced number of 'true positive'P3oo waves [-J]. J Psychiatr Res, 2000, 34 (3):255.
  • 5Mathalon DH, Ford JM, Pfefferbaum A. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study [J]. Biol Psychiatry, 2000, 47(5) : 434.
  • 6Snitz BE,MacDonald A 3rd,Cohen JD, et al. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment [J]. Am J Psy- chiatry, 2005, 162(12) : 2322.
  • 7Blackwood HRD, Glabus MF, Dunan J, at al. Altered cerebral perfusion measured by SPECT in relatives of pa- tients with schizophrenia. Correlations with memory and P300 [J]. BrJ Psychiatry, 1999, 175 357.
  • 8Horacek J,Bubenikova-Valesova V,Kopecek M,et al.Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia[J].CNS Drugs,2006,20(5):389.
  • 9Naber D,Lambert M.Aripiprazole:a new atypical antipsychotic with a different pharmacological mechanism[J].Prog Neuropsychopharmacol Biol Psychiatry,2004,28(8):1213.
  • 10Bardin L,Auclair A,Kleven MS,et al.Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity:comparison with typical and atypical conventional antipsychotics[J].Behav Pharmacol,2007,18(2):103.

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部